News

2019

company

year

domain

Evelo Biosciences Announces the Appointment of David Epstein as Chairman of its Board of Directors

Evelo Biosciences 09.17.2019

Foghorn® Therapeutics Expands Leadership Team With Two C-Suite Appointments

Foghorn Therapeutics 09.16.2019

Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944)

Moderna 09.12.2019

Quanterix Simoa Technology Powers Multiple Sclerosis Research With More Than 50 Presentations At ECTRIMS 2019

Quanterix 09.11.2019

Kintai Therapeutics Appoints Senior Executive Dr. Mark E. Nuttall as Chief Business Officer

09.11.2019

Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT™) in Immuno-oncology

09.09.2019

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL151 For Parkinson’s Disease And Launch Of Its Engage Parkinson’s Website

Denali Therapeutics 09.04.2019

Moderna Appoints Tracey Franklin as Chief Human Resources Officer

Moderna 09.04.2019

Kaleido Biosciences Presents Data from Clinical Study of KB195 in Patients with Urea Cycle Disorders at Society for the Study of Inborn Errors of Metabolism Annual Symposium

09.03.2019

Kintai Therapeutics Announces Collaborations with Leading Academic Centers to Identify Novel Targets for Cancer Therapeutics

08.27.2019

Loading